Type B aortic dissection (TBAD) Surgery
Conditions
Interventions
This retrospective study, conducted from January 2009 to July 2023, included 1,524 patients with aortic dissection who were treated with Thoracic endovascular aortic repair in the aortic dilation data
Sponsors
National Natural Science Foundation of China
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Age range: 18-80 years old 2. Patients with TBAD undergoing TEVAR surgery 3. Complete preoperative albumin, lymphocyte, and other blood test data available 4. No history of aortic surgery 5. No malignant tumor or connective tissue disease
Exclusion criteria
Exclusion criteria: 1. Traumatic or iatrogenic aortic dissection 2. Connective tissue diseases such as: 2.1. Marfan syndrome 2.2. Turner’s syndrome 2.3. Bicuspid aortic valve 2.4. Bechet’s disease 2.5. Ehlers-Danlos syndrome 2.6. Giant cell arteritis 2.7. Ankylosing spondylitis 2.8. Takayasu arteritis 3. Previous aortic surgery 4. History of malignancy 5. Patients with incomplete clinical data
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| All-cause mortality at (30 days and one year post-surgery) using telephonic surveys or medical records for data collection | — |
Secondary
| Measure | Time frame |
|---|---|
| Aortic-related adverse events (ARAEs) and major adverse cardiac and cerebrovascular events (MACCEs) at (30 days and one year post-surgery) using telephonic surveys or medical records for data collection | — |
Countries
China
Contacts
Public ContactWen Li
Outcome results
None listed